Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

NCT00854360 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

487

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis
Hayfever

Interventions

DRUG: Beclomethasone dipropionate HFA Nasal Aerosol
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.